IGF1 and prostate cancer: In order to do this, we studied IGF-1-stimulated invasion in the DU145 cell line, which is the only commercially available prostate cancer cell line without PTEN inactivating mutations and an intact, tightly regulated PI-3 kinase pathway[15-17].